26786-28-7 Usage
Description
5-bromo-2-phenylpyrimidin-4-ol is a pyrimidine derivative with a molecular formula C11H8BrN3O. It features a bromine atom at the 5th position, a phenyl group at the 2nd position, and a hydroxyl group at the 4th position. This chemical compound is widely recognized as a building block in organic synthesis and pharmaceutical research.
Uses
Used in Organic Synthesis:
5-bromo-2-phenylpyrimidin-4-ol is used as a building block for the synthesis of various organic compounds. Its unique structure and properties make it a valuable component in the creation of new molecules with potential applications in various fields.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 5-bromo-2-phenylpyrimidin-4-ol is utilized as an intermediate in the synthesis of biologically active compounds. Its presence in these compounds can contribute to their therapeutic effects, making it a crucial component in drug development.
Used in Medicinal Chemistry:
5-bromo-2-phenylpyrimidin-4-ol is also used as a starting material for the development of new drugs. Its unique structure allows researchers to explore its potential in creating novel therapeutic agents that can address unmet medical needs.
Used in Drug Development:
5-bromo-2-phenylpyrimidin-4-ol's properties make it a candidate for further research in medicinal chemistry and drug development. Its potential applications in creating new drugs and improving existing ones highlight its importance in the pharmaceutical sector.
Check Digit Verification of cas no
The CAS Registry Mumber 26786-28-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,7,8 and 6 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 26786-28:
(7*2)+(6*6)+(5*7)+(4*8)+(3*6)+(2*2)+(1*8)=147
147 % 10 = 7
So 26786-28-7 is a valid CAS Registry Number.
26786-28-7Relevant articles and documents
PYRIMIDINE COMPOUNDS AS TUBERCULOSIS INHIBITORS
-
Page/Page column 109, (2011/02/24)
The present invention relates to compounds II useful as inhibitors of treating tuberculosis. The invention also provides processes for preparing compounds of the invention.
SUBSTITUTED HETEROCYCLIC COMPOUNDS AND METHODS OF USE
-
Page/Page column 32, (2010/10/20)
The present invention relates to pyridines, pyrimidines and derivatives thereof, and pharmaceutically acceptable salts thereof. Also included is a method of treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic beta cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis, inflammatory bowel disease, adult respiratory distress syndrome (ARDS), psoriasis, Crohn's disease, allergic rhinitis, ulcerative colitis, anaphylaxis, contact dermatitis, asthma, muscle degeneration, cachexia, Reiter's syndrome, type I diabetes, type II diabetes, bone resorption diseases, graft vs. host reaction, Alzheimer's disease, stroke, myocardial infarction, ischemia reperfusion injury, atherosclerosis, brain trauma, multiple sclerosis, cerebral malaria, sepsis, septic shock, toxic shock syndrome, fever, myalgias due to HIV-1, HIV-2, HIV-3, cytomegalovirus (CMV), influenza, adenovirus, the herpes viruses or herpes zoster infection in a mammal comprising administering an effective amount a compound as described above.
